The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Everspin Technologies, Inc. , the world's leading developer and manufacturer of Magnetoresistive Random Access Memory (MRAM) persistent memory solutions, today announced that its PERSYST MRAM is now ...

Members of the public can stop by between 10 a.m. and 6 p.m. Tuesday through Sunday to meet Cain, or make an appointment to ...